• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国国家静脉血栓栓塞风险评估工具在二级医疗保健中的影响:基于人群的回顾性数据库研究

Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study.

作者信息

Catterick David, Hunt Beverly J

机构信息

aDepartment of Economics, City University London, London bHealth Outcomes Department, Sanofi, Guildford, Surrey cKing's College, London and Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Blood Coagul Fibrinolysis. 2014 Sep;25(6):571-6. doi: 10.1097/MBC.0000000000000100.

DOI:10.1097/MBC.0000000000000100
PMID:24686103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4162339/
Abstract

Venous thromboembolism (VTE) is a common and important cause of death in hospital patients. We therefore investigated possible associations between the introduction of the compulsory national VTE risk assessment tool in England in 2010 and patient outcomes. A retrospective database study, using data from the Health and Social Care Information Centre and Office of National Statistics, was undertaken. The main outcome measures were VTE-related secondary diagnosis rates, 30-day and 90-day readmission rates and mortality rates. The observed mean VTE-related secondary diagnosis rate for 2011-2012 was 91% of the rate estimated from a linear regression model of the data for 2006-2007 to 2010-2011 (P = 0.001). Similarly, the observed mean 30-day VTE-related readmission rate for 2011 was 96% of the estimated rate (P = 0.067) and the observed mean 90-day VTE-related readmission rate for 2011 was 96% of the estimated rate (P = 0.022). The observed annual VTE-related national mortality rate was 91% of the estimated rate for 2011 and 92% of the estimated rate for 2012. This study shows a reduction in VTE-related secondary diagnoses and readmissions among adults admitted to hospital, and a reduction in VTE-related population mortality, since the introduction of a national VTE risk assessment screening tool in England. Despite some study limitations, this suggests that the concerted effort made by NHS England to improve prevention of hospital-acquired VTE has been successful.

摘要

静脉血栓栓塞症(VTE)是住院患者常见且重要的死亡原因。因此,我们调查了2010年英格兰强制推行全国VTE风险评估工具与患者预后之间可能存在的关联。我们利用来自健康与社会保健信息中心及国家统计局的数据进行了一项回顾性数据库研究。主要结局指标为VTE相关的二次诊断率、30天和90天再入院率以及死亡率。2011 - 2012年观察到的VTE相关二次诊断率均值为根据2006 - 2007年至2010 - 2011年数据的线性回归模型估算率的91%(P = 0.001)。同样,2011年观察到的30天VTE相关再入院率均值为估算率的96%(P = 0.067),2011年观察到的90天VTE相关再入院率均值为估算率的96%(P = 0.022)。2011年观察到的全国VTE相关年度死亡率为估算率的91%,2012年为估算率的92%。这项研究表明,自英格兰引入全国VTE风险评估筛查工具以来,住院成人中VTE相关的二次诊断和再入院情况有所减少,VTE相关的总体死亡率也有所降低。尽管该研究存在一些局限性,但这表明英格兰国民保健服务体系为改善医院获得性VTE预防所做的协同努力取得了成功。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/66c000ec1515/blcof-25-571-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/5d31d64b4967/blcof-25-571-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/994f56706eec/blcof-25-571-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/346614fd4add/blcof-25-571-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/66c000ec1515/blcof-25-571-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/5d31d64b4967/blcof-25-571-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/994f56706eec/blcof-25-571-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/346614fd4add/blcof-25-571-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99e/4162339/66c000ec1515/blcof-25-571-g004.jpg

相似文献

1
Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study.英国国家静脉血栓栓塞风险评估工具在二级医疗保健中的影响:基于人群的回顾性数据库研究
Blood Coagul Fibrinolysis. 2014 Sep;25(6):571-6. doi: 10.1097/MBC.0000000000000100.
2
Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target.与住院相关的致命静脉血栓栓塞症:一项评估国家风险评估目标影响的队列研究。
Heart. 2013 Dec;99(23):1734-9. doi: 10.1136/heartjnl-2013-304479. Epub 2013 Sep 15.
3
A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.对出院后发生静脉血栓栓塞症的患者进行血栓预防治疗的回顾性研究。
N Z Med J. 2010 Feb 19;123(1309):37-49.
4
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).风险评估模型(Padua 预测评分和改善出血评分)在静脉血栓栓塞症、大出血和与药物预防 VTE 相关的卫生支出方面的临床影响:一项在单个内科病房住院患者中进行的“真实生活”前瞻性和回顾性观察研究(STIME 研究)。
Intern Emerg Med. 2018 Jun;13(4):527-534. doi: 10.1007/s11739-018-1808-z. Epub 2018 Mar 3.
5
Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope.因晕厥出院的患者发生静脉血栓栓塞症导致的 30 天再入院率。
PLoS One. 2020 Apr 13;15(4):e0230859. doi: 10.1371/journal.pone.0230859. eCollection 2020.
6
Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department.急诊科中接受阿哌沙班与华法林治疗静脉血栓栓塞的患者住院率比较。
Hosp Pract (1995). 2020 Feb;48(1):41-48. doi: 10.1080/21548331.2020.1718925. Epub 2020 Feb 6.
7
Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.静脉血栓栓塞和大出血是否可以作为肺癌死亡率的指标?一项全国性数据库研究。
BMC Cancer. 2020 May 24;20(1):461. doi: 10.1186/s12885-020-06930-1.
8
Hidden burden of venous thromboembolism after trauma: A national analysis.创伤后静脉血栓栓塞症的隐性负担:一项全国性分析。
J Trauma Acute Care Surg. 2018 Nov;85(5):899-906. doi: 10.1097/TA.0000000000002039.
9
A Clinical Tool for the Prediction of Venous Thromboembolism in Pediatric Trauma Patients.用于预测儿科创伤患者静脉血栓栓塞症的临床工具。
JAMA Surg. 2016 Jan;151(1):50-7. doi: 10.1001/jamasurg.2015.2670.
10
Readmission with venous thromboembolism after surgical treatment by primary cancer site.原发癌部位手术后因静脉血栓栓塞而再次入院。
Surg Oncol. 2020 Dec;35:268-275. doi: 10.1016/j.suronc.2020.09.013. Epub 2020 Sep 9.

引用本文的文献

1
Venous Thromboembolism Risk Assessment and Prophylaxis Administration among Admitted Patients in Lagos, Nigeria: A Quality Improvement Project.尼日利亚拉各斯住院患者的静脉血栓栓塞风险评估与预防管理:一项质量改进项目
Ethiop J Health Sci. 2025 May;35(3):179-184. doi: 10.4314/ejhs.v35i3.5.
2
Development and evaluation of a national administrative code-based system for estimation of hospital-acquired venous thromboembolism in Ireland.爱尔兰基于国家行政代码系统的医院获得性静脉血栓栓塞症评估体系的开发与评估
BMJ Open. 2025 Feb 20;15(2):e084951. doi: 10.1136/bmjopen-2024-084951.
3
Adequacy of Venous Thromboembolism Risk Assessment and Prophylaxis After Gastrointestinal Surgery in a Sudanese Teaching Hospital: A Prospective Audit.

本文引用的文献

1
A meta-analysis of hospital 30-day avoidable readmission rates.医院 30 天可避免再入院率的荟萃分析。
J Eval Clin Pract. 2012 Dec;18(6):1211-8. doi: 10.1111/j.1365-2753.2011.01773.x. Epub 2011 Nov 9.
2
Quality of primary care in England with the introduction of pay for performance.引入绩效薪酬后英国初级医疗保健的质量
N Engl J Med. 2007 Jul 12;357(2):181-90. doi: 10.1056/NEJMsr065990.
3
Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.评估、预防和治疗静脉血栓栓塞:循证方法
苏丹一家教学医院胃肠道手术后静脉血栓栓塞风险评估与预防的充分性:一项前瞻性审计
Cureus. 2024 Nov 9;16(11):e73316. doi: 10.7759/cureus.73316. eCollection 2024 Nov.
4
The potential use of artificial intelligence for venous thromboembolism prophylaxis and management: clinician and healthcare informatician perspectives.人工智能在静脉血栓栓塞症预防和管理中的潜在应用:临床医生和医疗信息学专家的观点。
Sci Rep. 2024 May 26;14(1):12010. doi: 10.1038/s41598-024-62535-9.
5
The Benefits and Imperative of Venous Thromboembolism Risk Screening for Hospitalized Patients: A Systematic Review.住院患者静脉血栓栓塞风险筛查的益处与必要性:一项系统评价
J Clin Med. 2023 Nov 9;12(22):7009. doi: 10.3390/jcm12227009.
6
Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study.在当前血栓预防策略背景下医院相关性血栓形成的发生情况:一项观察性横断面研究
TH Open. 2023 Sep 27;7(3):e280-e284. doi: 10.1055/a-2137-9531. eCollection 2023 Jul.
7
Systematic review on the benefit of graduated compression stockings in the prevention of venous thromboembolism in low-risk surgical patients.系统评价梯度压力弹力袜在低危手术患者中预防静脉血栓栓塞症的获益。
Phlebology. 2021 Apr;36(3):184-193. doi: 10.1177/0268355520958590. Epub 2020 Oct 4.
8
Prevention of health care associated venous thromboembolism through implementing VTE prevention clinical practice guidelines in hospitalized medical patients: a systematic review and meta-analysis.通过在住院内科患者中实施 VTE 预防临床实践指南预防医疗保健相关性静脉血栓栓塞症:系统评价和荟萃分析。
Implement Sci. 2020 Jun 24;15(1):49. doi: 10.1186/s13012-020-01008-9.
9
Is there a role for low-dose DOACs as prophylaxis?低剂量 DOAC 作为预防措施是否有作用?
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):187-193. doi: 10.1182/hematology.2019000026.
10
Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness.预防静脉血栓栓塞的干预措施组合:确保质量和有效性。
BMJ Open Qual. 2019 Jun 21;8(2):e000459. doi: 10.1136/bmjoq-2018-000459. eCollection 2019.
Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. doi: 10.2146/ajhp070108.
4
Identifying potentially preventable complications using a present on admission indicator.使用入院时存在指标识别潜在可预防的并发症。
Health Care Financ Rev. 2006 Spring;27(3):63-82.
5
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.肺栓塞后慢性血栓栓塞性肺动脉高压的发病率。
N Engl J Med. 2004 May 27;350(22):2257-64. doi: 10.1056/NEJMoa032274.
6
Natural history of venous thromboembolism.静脉血栓栓塞症的自然病史。
Circulation. 2003 Jun 17;107(23 Suppl 1):I22-30. doi: 10.1161/01.CIR.0000078464.82671.78.
7
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.依诺肝素与安慰剂预防急性病内科患者静脉血栓栓塞的比较。内科患者依诺肝素预防研究组。
N Engl J Med. 1999 Sep 9;341(11):793-800. doi: 10.1056/NEJM199909093411103.
8
The changing pattern of venous thromboembolic disease.静脉血栓栓塞性疾病的变化模式。
Haemostasis. 1996 Mar-Apr;26(2):65-71. doi: 10.1159/000217189.
9
Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.小剂量肝素预防术后致命性肺栓塞。一项国际多中心试验。
Lancet. 1975 Jul 12;2(7924):45-51.